Orchard Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	68.42	55.91	55.14	19.05	335.84	89.86	3.5
Short-Term Investments	75.33	164.2	136.81	305.94	0	0	0
Cash & Cash Equivalents	143.75	220.11	191.95	324.99	335.84	89.86	3.5
Cash Growth	-34.69%	14.67%	-40.94%	-3.23%	273.76%	2469.52%	-
Receivables	8.47	1.48	0.88	1.44	2.1	1.25	0.15
Inventory	3.4	0	0	0	0	0	0
Other Current Assets	12.53	53.73	30.71	23.46	17.57	3.12	0.33
Total Current Assets	168.15	275.32	223.54	349.9	355.52	94.22	3.98
Property, Plant & Equipment	30.91	29.08	34.6	27.01	5.48	2.71	0.18
Long-Term Investments	4.22	4.27	4.27	4.26	3.84	0	0
Goodwill and Intangibles	3.56	4.15	3.08	0	0	0	0
Other Long-Term Assets	12.08	9.59	15.46	18.11	1.21	0.36	0.12
Total Long-Term Assets	50.76	47.09	57.4	49.39	10.53	3.07	0.31
Total Assets	218.91	322.41	280.94	399.28	366.04	97.29	4.28
Accounts Payable	9.32	10.01	8.82	11.98	18.13	3.89	0.7
Deferred Revenue	11.27	12.87	0	0	0	0	0
Current Debt	15.85	8.12	13.8	5.89	0	0	1.4
Other Current Liabilities	24.12	11.8	28.94	37.98	29.78	6.86	1.72
Total Current Liabilities	60.57	42.79	51.56	55.86	47.91	10.76	3.82
Long-Term Debt	42.24	51.36	44.37	40.02	0	0	0
Other Long-Term Liabilities	17.84	18.3	6.57	4.21	6.8	0.13	0.02
Total Long-Term Liabilities	60.08	69.67	50.94	44.23	6.8	0.13	0.02
Total Liabilities	120.64	112.46	102.5	100.09	54.7	10.89	3.84
Total Debt	58.09	59.49	58.17	45.91	0	0	1.4
Debt Growth	-2.35%	2.27%	26.70%	-	-	-	-
Common Stock	973.13	956.93	783.7	750.81	598.41	142.02	3.4
Retained Earnings	-900.88	-750.22	-605.64	-453.66	-290.24	-59.74	-19.66
Comprehensive Income	26.02	3.25	0.37	2.04	3.16	4.13	-0.27
Shareholders' Equity	98.26	209.95	178.43	299.19	311.34	86.41	-16.52
Net Cash / Debt	85.66	160.62	133.78	279.08	335.84	89.86	2.1
Net Cash / Debt Growth	-46.67%	20.06%	-52.06%	-16.90%	273.76%	4189.07%	-
Net Cash Per Share	0.67	1.30	1.35	2.99	14.89	10.13	0.30
Working Capital	107.58	232.53	171.97	294.04	307.61	83.47	0.16
Book Value Per Share	7.68	16.94	17.94	32.09	138.01	97.38	-23.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).